TA · Healthcare

Nextage Therapeutics Ltd (NXTG)

Drug Manufacturers - Specialty & Generic

Nextage Therapeutics Ltd (NXTG) is listed on TA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NXTG

P/E ratio

18.00

Nextage Therapeutics Ltd (NXTG) — FAQ

What is NXTG's P/E ratio?

The price-to-earnings (P/E) ratio for Nextage Therapeutics Ltd (NXTG) is 18.00 (data as of 2026-05-24).

Does Nextage Therapeutics Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Nextage Therapeutics Ltd (NXTG). Check the MyAverix Finance app for the latest dividend data.

What sector is Nextage Therapeutics Ltd in?

Nextage Therapeutics Ltd (NXTG) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is NXTG listed on?

NXTG is listed on TA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)